Stroke at baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): a cross-sectional analysis

Imagem de Miniatura
Arquivos
art_ABREU_Stroke_at_baseline_of_the_Brazilian_Longitudinal_Study_2018.PDF (183.61 KB)
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2018
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOCIACAO PAULISTA MEDICINA
Autores
Citação
SAO PAULO MEDICAL JOURNAL, v.136, n.5, p.398-406, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: Secondary prevention of stroke is a very important goal for achieving continuous reduction in stroke mortality rates over the next decades. DESIGN AND SETTING: Cross-sectional analysis on the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), with data from Salvador, Vitoria, Belo Horizonte, Rio de Janeiro, Sao Paulo and Porto Alegre. METHODS: This descriptive analysis focused on secondary prevention of stroke among participants who self-reported a medical diagnosis of stroke at the baseline of ELSA-Brasil, and its association with sociodemographic characteristics. RESULTS: Overall, 197 participants (13%) reported a prior medical history of stroke. Participants with stroke were older and less educated and had lower mean monthly family income, compared with nonstroke participants. Among all stroke cases, 23.7% did not use any medication for secondary prevention of stroke. Use of secondary prevention was higher among men than among women (respectively, 59.6% versus 40.4%; P = 0.02 for aspirin; and 71.4% versus 28.6%; P = 0.04 for other antiplatelet drugs). Having private health insurance was associated with greater use of less cost-effective and more expensive medications (like angiotensinogen receptor blockers) and a tendency to use antiplatelet drugs other than aspirin, among participants reporting stroke, compared with others. Use of medication decreased as time passed after suffering a stroke. CONCLUSIONS: In this sample of individuals with better access to healthcare services, use of secondary prevention for stroke was low, which may suggest that the situation in the general population is worse. Sex was the most important sociodemographic variable associated with low use of secondary prevention.
Palavras-chave
Cerebrovascular disorders, Stroke, Risk factor, Secondary prevention
URI
https://observatorio.fm.usp.br/handle/OPI/29825
Referências
  1. AQUINO EML, 1992, REV SAUDE PUBL, V26, P195, DOI 10.1590/S0034-89101992000300011
  2. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  3. Bensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780
  4. Brasil. Ministerio da Saude Fundacao Oswaldo Cruz, 2005, PROGR FARM POP BRAS
  5. Brasil. Ministerio da Saude. Secretaria de Ciencia Tecnologia e Insumos Estrategicos. Departamento de Assistencia Farmaceutica e Insumos Estrategicos., 2015, REL NAC MED ESS RENA
  6. Cabral Norberto L, 2012, Am J Public Health, V102, pe90, DOI 10.2105/AJPH.2012.301024
  7. Carrington MJ, 2013, J HYPERTENS, V31, P1265, DOI 10.1097/HJH.0b013e3283606bc7
  8. Chor D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127382
  9. Dal Pizzol TD, 2010, CAD SAUDE PUBLICA, V26, P827, DOI 10.1590/S0102-311X2010000400024
  10. Fasce E, 2007, J HYPERTENS, V25, P1807, DOI 10.1097/HJH.0b013e328244e481
  11. Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P230, DOI 10.1159/000441106
  12. Fernandes TG, 2015, INT J STROKE, V10, P34, DOI 10.1111/ijs.12526
  13. Gamboa CM, 2017, J AM HEART ASS, V6
  14. Guerra AA, 2004, REV PANAM SALUD PUBL, V15, P168, DOI 10.1590/S1020-49892004000300005
  15. Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026
  16. Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024
  17. Kim Yeon-Yong, 2017, J Prev Med Public Health, V50, P294, DOI 10.3961/jpmph.17.024
  18. KOUTIS A D, 1991, Scandinavian Journal of Primary Health Care, V9, P297, DOI 10.3109/02813439109018536
  19. Lotufo PA, 2013, INT J STROKE, V8, P155, DOI 10.1111/j.1747-4949.2011.00757.x
  20. Lotufo PA, 2009, INT J STROKE, V4, P40, DOI 10.1111/j.1747-4949.2009.00240.x
  21. Lotufo Paulo Andrade, 2017, Rev. bras. epidemiol., V20, P129, DOI 10.1590/1980-5497201700050011
  22. Lotufo PA, 2015, SAO PAULO MED J, V133, P457, DOI 10.1590/1516-3180.2015.13360510
  23. Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851
  24. Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82
  25. Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255
  26. Santos IS, 2014, ATHEROSCLEROSIS, V237, P227, DOI 10.1016/j.atherosclerosis.2014.09.004
  27. Pinto CDS, 2010, REV SAUDE PUBL, V44, P611, DOI 10.1590/s0034-89102010005000021
  28. Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
  29. Stoverinck MJM, 1996, J FAM PRACTICE, V43, P567
  30. Vianna CA, 2012, CAD SAUDE PUBLICA, V28, P1122, DOI 10.1590/S0102-311X2012000600011
  31. Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
  32. Yamauti SM, 2015, CAD SAUDE PUBLICA, V31, P1648, DOI 10.1590/0102-311X00054814
  33. Bermudez JAZ, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.201605000SUPL2AP, 10.1590/s1518-8787.201605000supl2ap]

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HU
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - LIM/51
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/10